Head and Neck Cancer
📧 Sign up to get email alerts when something new happens for Head and Neck Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-01-20Clinical Trial Update: The HEART Study (Healthy Eating and Recovery Together) [NA]
The HEART Study (Healthy Eating and Recovery Together) completed enrollment with results posted; focuses on head and neck cancer survivorshi…
-
CLINICAL_TRIALS trial_result · 2023-01-09Clinical Trial Update: Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery [Phase 3]
Phase 3 trial update on using fluorescence for sentinel lymph node identification in cancer surgery; completed study.
-
CLINICAL_TRIALS trial_result · 2022-12-27Clinical Trial Update: Evaluating Chinese Medicine Oral Rinse for Irradiated Oral Mucositis in Head & Neck Cancer Patients [Phase 1, Phase 2]
A clinical trial evaluating a Chinese medicine oral rinse for radiation-induced oral mucositis in head and neck cancer patients across Phase…
-
CLINICAL_TRIALS trial_result · 2022-12-15Clinical Trial Update: BEMPEG With Pembrolizumab vs Pembrolizumab Alone in Patients With Metastatic or Recurrent HNSCC (PROPEL-36) [Phase 2, Phase 3]
A phase 2/3 trial evaluating bempeg with pembrolizumab versus pembrolizumab alone in metastatic or recurrent head and neck cancer was termin…
-
CLINICAL_TRIALS trial_result · 2022-12-01Clinical Trial Update: Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients [Phase 2]
Phase 2 clinical trial evaluating skin rash management before chemotherapy in colorectal and head and neck cancer patients has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-11-18Clinical Trial Update: A Randomized Phase II Study on the Optimization of Immunotherapy in Squamous Carcinoma of the Head and Neck [Phase 2]
A randomized Phase II trial evaluating optimization of immunotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck…
-
CLINICAL_TRIALS trial_result · 2022-11-16Clinical Trial Update: Benzydamine Oromucosal Solution in Oral Mucositis (BOOM) [Phase 4]
Phase 4 clinical trial update for benzydamine oromucosal solution in Radiation-Induced Mucositis associated with head and neck cancer.
-
CLINICAL_TRIALS trial_result · 2022-11-16Clinical Trial Update: Nutrition and Pharmacological Algorithm for Oncology Patients Study [Phase 4]
Phase 4 trial update for a nutrition and pharmacological algorithm in oncology patients; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2022-11-10Clinical Trial Update: Panitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastatic Lymph Nodes in Patients With Head&Neck Cancer [Phase 2]
Phase 2 trial comparing panitumumab-IRDye800 imaging against sentinel node biopsy and selective neck dissection for identifying metastatic l…
-
CLINICAL_TRIALS trial_result · 2022-11-03Clinical Trial Update: Phase II Trial: uPAR-PET/CT for Prognostication in Head- and Neck Cancer [Phase 2]
Phase II trial evaluating uPAR-PET/CT for prognostication in head and neck cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2022-10-19Clinical Trial Update: Quantitative Endoscopy of H&N [Phase 2]
Phase 2 trial evaluating quantitative endoscopy for head and neck cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2022-10-18Clinical Trial Update: Minocycline for Postsurgical Symptom Reduction in Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating minocycline for postsurgical symptom reduction in head and neck cancer was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2022-09-29Clinical Trial Update: Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC [Phase 2, Phase 3]
A clinical trial evaluating cisplatin and radiotherapy with or without gemcitabine, carboplatin, and paclitaxel in locally advanced head and…
-
CLINICAL_TRIALS trial_result · 2022-09-23Clinical Trial Update: Induction Immunochemotherapy in Stage III-IVa Head and Neck Cancer [Phase 2]
Phase 2 clinical trial update on induction immunochemotherapy for stage III-IVa head and neck cancer.
-
CLINICAL_TRIALS trial_result · 2022-09-19Clinical Trial Update: Central Pain Syndrome in Survivors of Head and Neck Cancer [NA]
A terminated clinical trial at Vanderbilt-Ingram Cancer Center investigated central pain syndrome in survivors of head and neck cancer; resu…
-
CLINICAL_TRIALS trial_result · 2022-08-25Clinical Trial Update: Safety and Efficacy of MEDI0457 and Durvalumab in Participants With Human Papilloma Virus (HPV) Associated Recurrent/Metastatic Head and Neck Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating MEDI0457 with Durvalumab in HPV-positive recurrent/metastatic head and neck cancer has completed with posted resu…
-
CLINICAL_TRIALS trial_result · 2022-08-16Clinical Trial Update: Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck Cancer [Phase 2]
Phase 2 open-label study evaluating GC4419 to reduce severity of oral mucositis associated with chemoradiotherapy in head and neck cancer; s…
-
CLINICAL_TRIALS trial_result · 2022-08-05Clinical Trial Update: Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating pemetrexed and gemcitabine in advanced head and neck cancer; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2022-05-25Clinical Trial Update: Skin Changes in Head and Neck Cancer During Immuno-(Chemo-) And Radiotherapy With Erbitux® (HICARE) [Phase 4]
Phase 4 trial update examining skin changes during immuno-(chemo-) and radiotherapy with Erbitux in head and neck cancer.
-
CLINICAL_TRIALS trial_result · 2022-05-11Clinical Trial Update: The Use of Tulsi Extract for The Management of Oral Mucositis in Head & Neck Cancer Patients Undergoing Radiotherapy [Phase 2]
Phase 2 clinical trial evaluating tulsi extract for managing oral mucositis in head and neck cancer patients undergoing radiotherapy.
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: Post-operative Radiation With Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck [Phase 2]
Phase 2 trial assessing postoperative radiation with cetuximab for locally advanced cutaneous squamous cell carcinoma of the head and neck c…
-
CLINICAL_TRIALS trial_result · 2022-05-03Clinical Trial Update: Study of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 3]
Phase 3 trial comparing nivolumab plus ipilimumab vs standard of care in first-line recurrent/metastatic squamous cell carcinoma of the head…
-
CLINICAL_TRIALS trial_result · 2022-04-21Clinical Trial Update: Afatinib and Pembrolizumab for Head and Neck Squamous Cell Carcinoma (ALPHA Study) [Phase 2]
Phase 2 trial update on afatinib plus pembrolizumab for head and neck squamous cell carcinoma (ALPHA Study) completed.
-
CLINICAL_TRIALS trial_result · 2022-04-21Clinical Trial Update: Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 2]
Phase 2 trial evaluating nivolumab plus ipilimumab versus nivolumab plus ipilimumab placebo in recurrent or metastatic squamous cell carcino…
-
CLINICAL_TRIALS trial_result · 2022-04-08Clinical Trial Update: Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Head and Neck Cancer [Phase 2]
Phase 2 rollover study of weekly paclitaxel (BMS-181339) in patients with head and neck cancer has completed with posted results.